NEW YORK--(BUSINESS WIRE)--In the first of several moves to expand the Company’s position as a national provider of esoteric and high value diagnostics, Enzo Biochem, Inc. (NYSE:ENZ) announced today that its Enzo Clinical Labs division has been awarded a license for doing business in the Commonwealth of Pennsylvania, the first of several for which it has applied.
